Breast Cancer Clinical Trial
A Study of LY3435151 in Participants With Solid Tumors
Summary
The reason for this study is to see if the study drug LY3435151 is safe in participants with advanced solid tumors.
Eligibility Criteria
Inclusion Criteria:
Participant must have certain types of cancer, which your study doctor will discuss with you
Participant must have stopped other forms of treatment for cancer, which your study doctor will discuss with you
Participant must be able and willing to provide a sample of your tumor before beginning treatment and once while on treatment. For certain tumor types, the outcome of the biopsy may exclude you from the study treatment (for Phase 1b)
Participant must agree to use birth control
Participant must have progressed through or are intolerant to therapies with known clinical benefit, which your study doctor will discuss with you
Exclusion Criteria:
Participant must not have a history of tuberculosis, uncontrolled HIV or uncontrolled hepatitis B or C virus infection
Participant must not have an autoimmune disease, which your study doctor will discuss with you
Participant must not use corticosteroids, which your study doctor will discuss with you
Participant must not have heart disease, Crohn's disease or brain cancer
Participant must not be pregnant or breastfeeding
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 2 Locations for this study
Houston Texas, 77030, United States
Chuo-Ku Tokyo, 104-0, Japan
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.